Eva Feldman

Eva Feldman

FDA Approves Phase II Of U-M Stem Cell Trial For ALS

For nearly two years, University of Michigan neurologist Eva Feldman, M.D., has led the nation’s first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig’s disease.

WWJ Newsradio 950–04/17/2013

University of Michigan Hospital (University of Michigan photo)

ALS Patients Approved For More Stem Cells

Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.

WWJ Newsradio 950–05/09/2012

Awards and Certifications From September 21

The latest awards and industry certifications from Michigan’s technology-focused companies and institutions

WWJ Newsradio 950–09/21/2011

Stem Cell Summit: Cure For Paralysis And More?

More news on clinical trials for stem cell cures for some of mankind’s most dreaded diseases emerged Tuesday from the World Stem Cell Summit in Detroit. Thomas Okarma, president and CEO of Menlo Park, Calif.-based […]

10/05/2010

Follow

Get every new post delivered to your Inbox.

Join 1,975 other followers